NCT07015697
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
AZN — ASTRAZENECA PLC
Phase 1
• Recurrent or Metastatic Solid Tumors
TL;DR
Locations updated — PHASE1
What changed
Recent events (last 90 days)
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.